Your browser doesn't support javascript.
loading
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
McCleary-Wheeler, Angela L; Carr, Ryan M; Palmer, Shanique R; Smyrk, Thomas C; Allred, Jacob B; Almada, Luciana L; Tolosa, Ezequiel J; Lamberti, Maria J; Marks, David L; Borad, Mitesh J; Molina, Julian R; Qi, Yingwei; Lingle, Wilma L; Grothey, Axel; Pitot, Henry C; Jatoi, Aminah; Northfelt, Donald W; Bryce, Alan H; McWilliams, Robert R; Okuno, Scott H; Haluska, Paul; Kim, George P; Colon-Otero, Gerardo; Lowe, Val J; Callstrom, Matthew R; Ma, Wen We; Bekaii-Saab, Tanios; Hung, Mien-Chie; Erlichman, Charles; Fernandez-Zapico, Martin E.
Afiliación
  • McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Carr RM; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Palmer SR; Department of Hematology and Oncology, Mid-Atlantic Permanente Medical Group, Wood Lawn, MD, USA.
  • Smyrk TC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Allred JB; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Lamberti MJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Borad MJ; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Molina JR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Qi Y; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Lingle WL; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Grothey A; Department of Medical Oncology, West Cancer Center, Germantown, TN, USA.
  • Pitot HC; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Jatoi A; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Northfelt DW; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Bryce AH; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • McWilliams RR; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Okuno SH; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Haluska P; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Kim GP; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Colon-Otero G; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Lowe VJ; Department of Nuclear Medicine, Mayo Clinic, Rochester, MN, USA.
  • Callstrom MR; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Ma WW; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Bekaii-Saab T; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Hung MC; Center for Molecular Medicine and Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Erlichman C; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: Fernandez-zapico.martin@mayo.edu.
Pancreatology ; 20(1): 101-109, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31787526
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Piridinas / Clorhidrato de Erlotinib / Anilidas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Piridinas / Clorhidrato de Erlotinib / Anilidas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pancreatology Asunto de la revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos